Recent Finacing
Recent Raise
Revance Therapeutics develops botulinum toxin therapies and a TransMTS transdermal delivery platform, advancing RT001 topical gel and RT002 injectable neurotoxin across aesthetic and therapeutic indications.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
